The below chart shows the sources of funding for R&D investment in Italy, with only 7% of total investment originating from pharmaceutical and health-oriented biotech.
Click here to read more articles and interviews from Italy, and to download the latest free pharma report on the country.
Click here to read more articles and interviews from Italy, and to download the latest free pharma report on the country.